Clinical Trial Update: Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating single antiplatelet therapy with ticagrelor or aspirin following transcatheter aortic valve implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Aspirin (Aspirin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Fundacin Biomedica Galicia Sur | Conditions: Severe Aortic Valve Stenosis, Aortic Valve Stenosis | Phase 4 | Status: UNKNOWN